Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2003
10/29/2003CN1451747A Medusa cystatin gene, and expression and use thereof
10/29/2003CN1451666A Recombinant fusion resisting tomur attack and transfer
10/29/2003CN1451661A European verbena herb extract, and preparing process and use thereof
10/29/2003CN1451420A Material capable of preparing anticancer medicine and use thereof
10/29/2003CN1451413A Flavoured siberian solomonseal rhizome decoction and preparing process thereof
10/29/2003CN1451400A Medicine for preventing and treating tumor and preparing process thereof
10/29/2003CN1451393A Clam extract, and preparing process and use thereof
10/29/2003CN1451390A Medicine use of cyclodextrin derivs. and medicine composition thereof
10/29/2003CN1451379A Curcuma longa extract injection, and preparing process and use thereof
10/29/2003CN1451378A ÔÇ£MaolansuÔÇØ fat emulsion as antineoplastic medicine and preparing process
10/29/2003CN1451376A Curcuma aromatica extract injection, and preparing method and use thereof
10/29/2003CN1125652C Wu Zuze
10/29/2003CN1125601C Powdered prolycopene preparation, mfg. method thereof and use of same
10/28/2003US6639111 Bind on EP4 subtype receptor selectively and binds on the other subtype receptors weakly; side-effect reduction; autoimmune diseases; asthma; bone disorders; degenerative nerve diseases; sleeping disorders; anticoagulants
10/28/2003US6639105 For inhibiting tumor cell growth
10/28/2003US6639089 Anticancer agents, perfumes or foods and drinks
10/28/2003US6639060 DNA segment encoding a receptor protein related to the erbB proto-oncogene family which previously has not been known; tool for screening for anticancer agents
10/28/2003US6639055 Method for making humanized antibodies
10/28/2003US6638973 Taxane formulations
10/28/2003US6638964 Sulfonamide-containing indole compounds
10/28/2003US6638962 Cycloheptene compounds
10/28/2003US6638957 Inhibition of 1-deoxy-D-xylulose-5-phosphate metabolic pathway
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638945 Quinoline derivatives as inhibitors of MEK enzymes
10/28/2003US6638944 Have urea containing substituent at 1-position; induce biosynthesis of cytokines such as interferon and tumor necrosis factor, exhibit antiviral and antitumor properties
10/28/2003US6638939 6,7-dimethoxyquinazolines and therapeutic use thereof
10/28/2003US6638935 Heteroary1 derivatives and their use as medicaments
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003US6638922 4-dedimethylaminotetracycline derivatives
10/28/2003US6638914 Pharmaceutical administration of adenosine agonists
10/28/2003US6638767 Methods for delivering compounds into a cell
10/28/2003US6638762 Tissue-vectors specific replication and gene expression
10/28/2003US6638747 Isolated polypeptide having specified amino acid sequence
10/28/2003US6638736 Gene expression inhibition; cancer and neurodegenerative disease diagnosis; molecular hybridization
10/28/2003US6638727 Intraductally administering an estrogen activity modulator
10/28/2003US6638530 N-(2-anilino)- and pyridino- substituents; mixed with polyoxyethylene glycol and surfactant, mineral acid salt of amino acid or propylene carbonate; absorbability; anticarcinogenic agents, immunosuppressants
10/28/2003US6638512 Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigens
10/28/2003US6638505 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer
10/28/2003US6638504 Methods for treating cancer
10/28/2003US6638502 Comprising nucleic acid sequence encoding an amino terminal fragment of urokinase that comprises and epidermal growth factor-like domain; gene expression control; antimetastasis agents
10/28/2003US6638500 Polyol-IFN-βconjugates modified at Cys-17 and composition containing same
10/28/2003CA2283939C Non-antigenic branched polymer conjugates
10/28/2003CA2253796C Inhibition of matrix metalloproteases by acetylene containing compounds
10/28/2003CA2252701C Halo-substituted protein kinase c inhibitors
10/28/2003CA2118010C Antibodies specific for carcinoma-associated antigens
10/28/2003CA2101179C Phenylimidazolidine derivatives, their preparation and their use
10/23/2003WO2003087841A2 An ephrin-b receptor protein involved in carcinoma
10/23/2003WO2003087840A2 Protein involved in cancer
10/23/2003WO2003087832A2 Diagnosis of carcinoma using raigi polypeptides
10/23/2003WO2003087818A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction
10/23/2003WO2003087411A1 Method to inhibit cell growth using oligonucleotides
10/23/2003WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003WO2003087374A1 Derivatives of the il-2 receptor gamma chain, their production and use.
10/23/2003WO2003087369A2 Ribozyme capable of specifically cleaving mmp-13
10/23/2003WO2003087344A1 New strains capable of producing conjugated linoleic acid, capsulated composition comprising them, and the preparation methods thereof
10/23/2003WO2003087338A2 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003WO2003087333A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003WO2003087319A2 Carcinoembryonic antigen cell adhesion molecule 1 (ceacam1) structure and uses thereof in drug identification and screening
10/23/2003WO2003087318A2 Truncated 24 kda basic fibroblast growth factor
10/23/2003WO2003087308A2 Use of interleukin-24 to treat ovarian cancer
10/23/2003WO2003087307A2 Use of interleukin-19 to treat cervical cancer
10/23/2003WO2003087306A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003WO2003087304A2 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003WO2003087296A2 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
10/23/2003WO2003087196A1 Thermogelling oligopeptide polymers
10/23/2003WO2003087174A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers
10/23/2003WO2003087160A1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells
10/23/2003WO2003087131A2 Anti-her2 antibody variants
10/23/2003WO2003087126A2 Heteroclitic analogs and related methods
10/23/2003WO2003087120A1 Estrone derivative and process for producing the same
10/23/2003WO2003087108A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087101A1 Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles
10/23/2003WO2003087095A1 Quinolinone derivatives
10/23/2003WO2003087087A2 Heterocyclic compounds and their use as modulators of p38 map kinase
10/23/2003WO2003087065A1 Inhibitors of glycinamide ribonucleotide transformylase
10/23/2003WO2003087062A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
10/23/2003WO2003087061A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003087060A1 Fredericamycin derivatives
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087055A1 Improved cc-1065 analog synthesis
10/23/2003WO2003087042A1 Occlusive composition comprising a poly (2-cyanoacrylate) monomer
10/23/2003WO2003087040A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087026A1 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003WO2003086467A1 Cancer treatment method comprising administering an erb-family inhibitor and a raf and/or ras inhibitor
10/23/2003WO2003086461A2 Use of substances for treating tumors
10/23/2003WO2003086459A1 Methods of treatement using ctla-4 antibodies
10/23/2003WO2003086458A1 Recombinant anti-interleukin-9 antibodies
10/23/2003WO2003086456A2 Anti-ck18 monoclonal antibody and therapeutic and diagnostic uses thereof in cancer
10/23/2003WO2003086455A1 Immunoadjuvant
10/23/2003WO2003086426A1 A set of chinese medicine for preventing and treating cancer
10/23/2003WO2003086424A1 Pharmaceutical composition comprising arsenite for the treatment of malignancy
10/23/2003WO2003086415A1 Method for inhibiting bone resorption with an alendronate and vitamin d formulation
10/23/2003WO2003086404A1 Fused quinoxaline derivatives as inhibitors of akt activity
10/23/2003WO2003086403A1 Inhibitors of akt activity
10/23/2003WO2003086397A1 Medicine for treating cancer
10/23/2003WO2003086395A1 Tyrosine kinase inhibitors
10/23/2003WO2003086394A1 Inhibitors of akt activity
10/23/2003WO2003086390A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003086386A1 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures
10/23/2003WO2003086383A1 Non-toxic amounts of protein-aggregating substances stimulate hsp70 expression and function as anti-tumor agents
1 ... 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 ... 2211